HIV/AIDS HAART
HIV/AIDS patients on efavirenz therapy have high-density lipoprotein cholesterol increase
Published in AIDS Weekly, July 10th, 2006
In a recent article published in the British Journal of Clinical Pharmacology, scientists in Portugal conducted a study to "investigate the long-term effects of efavirenz on cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein (LDL-C) and triglycerides (TG)."
"Thirty-four HIV-infected patients who commenced efavirenz therapy were monitored for 36 months."
"In patients with baseline HDL-C <40 mg/dL-1," wrote S.A. Pereira and colleagues at the New University...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-07-10)
More Articles from AIDS Weekly
- HIV/AIDS Screening
Risk-based HIV testing does not detect majority of infected persons in healthcare settings - HIV/AIDS Transmission
Simian HIV spreads quickly to systemic tissues after mucosal transmission - HIV/AIDS Vertical Transmission
Perinatal HIV transmission may be prevented by neutralizing antibodies - HIV/Leishmania Coinfection
HIV-1 indirectly affects uptake of Leishmania inside monocyte-derived macrophages - Business Update
Medical Services reports documentation complete for CE approval on HIV test kit in Europe - Candidiasis
Montreal researchers identify defective immune cells that determine susceptibility to candidiasis - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
